Madison Avenue Partners »

Merrimack Pharma shares owned by Madison Avenue Partners

Quarter-by-quarter ownership of Merrimack Pharma shares owned by Madison Avenue Partners from 13F filings

Historical chart of Madison Avenue Partners investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Madison Avenue Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Madison Avenue Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.7M 387k 14.77
2023-12-31 $7.4M 553k 13.41
2023-09-30 $6.8M 553k 12.33
2023-06-30 $6.8M 553k 12.30
2023-03-31 $6.8M 553k 12.29

More positions owned by Madison Avenue Partners

Solventum Corp Com Shs (SOLV)
Graham Hldgs Com Cl B (GHC)
Liberty Broadband Corp Com Ser C (LBRDK)
Wiley John & Sons Cl A (WLY)
Globus Med Cl A (GMED)
Theravance Biopharma (TBPH)
Stagwell Com Cl A (STGW)
Quidel Corp (QDEL)
Indivior Ord (INDV)
Nelnet Cl A (NNI)
Ducommun Incorporated (DCO)
Endeavor Group Hldgs Cl A Com (EDR)
Innovex International (INVX)
2seventy Bio Common Stock (TSVT)
News Corp Cl A (NWSA)

View all positions for Madison Avenue Partners

Top funds holding Merrimack Pharma

Massmutual Trust
Farther Finance Advisors
NISA Investment Advisors

View all funds holding Merrimack Pharma